Amphastar Pharmaceuticals, Inc. (AMPH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Amphastar Pharmaceuticals is a fully integrated business with extensive in-house product development capabilities and advanced analytical techniques [3] - The company conducts in-house animal studies and has fully integrated manufacturing processes, producing several of its own active pharmaceutical ingredients (APIs) [3] - All finished products are manufactured in the United States across three plants [3] Growth Strategy - Amphastar employs a dual growth strategy, focusing primarily on development [4]